Search results (727)
« Back to PublicationsBiobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy
Journal article
Chan JH. et al, (2026), Circulation: Genomic and Precision Medicine
Discovery of gene-alcohol interaction loci influencing blood pressure in 1.1 million individuals from multiple populations.
Preprint
Feitosa M. et al, (2026)
Rational discovery of therapeutic PAK1 allosteric activators
Journal article
He Y. et al, (2026), Cell
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation: Evidence for an Atrial-First Phenotype.
Journal article
da Rocha GL. et al, (2026), Journal of the American College of Cardiology, 87, 1279 - 1299
Hypertrophic cardiomyopathy caused by filamin-C variants has restrictive and extracardiac features and a distinctive ECG
Journal article
de Villiers C. et al, (2026), Heart Rhythm
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.
Preprint
Kramarenko DR. et al, (2026)
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.
Journal article
Beyhoff N. et al, (2026), JACC. Cardiovascular imaging, 19, 133 - 135
Myocardial Entropy and Risk Predictors in Hypertrophic Cardiomyopathy: An Analysis From the NHLBI HCM Registry
Journal article
Antiochos P. et al, (2025), Circulation: Cardiovascular Imaging, 18
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database.
Journal article
Gudmundsson S. et al, (2025), Nature communications, 16
Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.
Journal article
Mangino M. et al, (2025), Journal of the American College of Cardiology, 86, 400 - 403
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
Journal article
Saberi S. et al, (2025), JACC. Heart failure, 13
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy
Journal article
Wang Y-J. et al, (2025), Science Translational Medicine, 17
Considerations for drug trials in hypertrophic cardiomyopathy.
Journal article
Farrant JP. et al, (2025), ESC heart failure, 12, 1095 - 1112
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
Journal article
Leinhos L. et al, (2025), Scientific Reports, 15
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy
Journal article
Tadros R. et al, (2025), Nature Genetics, 57, 530 - 538